Riluzole Oral Soluble film (ROSF) 50 mg
17MO1R-0012
Phase 2 small_molecule terminated
Quick answer
Riluzole Oral Soluble film (ROSF) 50 mg for Amyotrophic Lateral Sclerosis is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aquestive Therapeutics
- Indication
- Amyotrophic Lateral Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated